A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1

A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1

Background Immune related adverse events (irAEs) are common side effects of checkpoint inhibitory (CPI) therapies targeting CTLA-4 and PD-1/PD-L1. Grover’s disease is an uncommon dermatologic condition with unclear pathogenesis previously reported as an irAE with ipilimumab.Case Presentation We repo...

Full description

Bibliographic Details
Main Authors: Patrick Hwu, Cara Haymaker, Chantale Bernatchez, Marc Uemura, Adi Diab, Natalie McQuail, Elizabeth Sirmans, Faisal Faˈak, Courtney W. Hudgens, Lydia Barbara, Jonathan L. Curry, Michael T. Tetzlaff
Format: Article
Language:English
Published: BMJ Publishing Group 2016-11-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/4/1/55.full

Internet

https://jitc.bmj.com/content/4/1/55.full

Similar Items